{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:36:29Z","timestamp":1790314589107,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","content-domain":{"domain":["gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.ygyno.2013.08.020","type":"journal-article","created":{"date-parts":[[2013,8,27]],"date-time":"2013-08-27T06:02:40Z","timestamp":1377583360000},"page":"694-700","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["PET\/CT in the staging of patients with a pelvic mass suspicious for ovarian cancer"],"prefix":"10.1016","volume":"131","author":[{"given":"H.","family":"Dauwen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Van Calster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.M.","family":"Deroose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Op de Beeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Amant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Neven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Berteloot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Leunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Timmerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Vergote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2013.08.020_bb0005","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1097\/01.AOG.0000220516.34053.48","article-title":"Diagnosis and management of epithelial ovarian cancer","volume":"107","author":"Bhoola","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2013.08.020_bb0010","first-page":"1055","article-title":"Carcinoma of the ovary","volume":"73","author":"Weekes","year":"1981","journal-title":"J Natl Med Assoc"},{"key":"10.1016\/j.ygyno.2013.08.020_bb0015","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.ejca.2009.12.014","article-title":"Estimates of cancer incidence and mortality in Europe in 2008","volume":"46","author":"Ferlay","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ygyno.2013.08.020_bb0020","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1006\/gyno.2000.5805","article-title":"Long-term results and prognostic factors in patients with epithelial ovarian cancer","volume":"78","author":"Brun","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.08.020_bb0025","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0020-7292(06)60033-7","article-title":"Carcinoma of the ovary FIGO 6th annual report on the results of treatment in gynecological cancer","volume":"95","author":"Heintz","year":"2006","journal-title":"Int J Gynaecol"},{"key":"10.1016\/j.ygyno.2013.08.020_bb0030","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/jnci\/95.2.113","article-title":"Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European organization for research and treatment of cancer-adjuvant chemotherapy in ovarian neoplasm trial","volume":"95","author":"Trimbos","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ygyno.2013.08.020_bb0035","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJMoa0908806","article-title":"Neo-adjuvant chemotherapy or primary surgery in stage IIIc or IV ovarian cancer","volume":"363","author":"Vergote","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ygyno.2013.08.020_bb0040","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1245\/s10434-011-2100-x","article-title":"Primary debulking surgery versus neoadjuvant chemotherapy in stage IV ovarian cancer","volume":"19","author":"Rauh-Hain","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ygyno.2013.08.020_bb0045","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.ygyno.2012.02.033","article-title":"Trends in therapy and survival of advanced stage epithelial ovarian cancer patients in the Netherlands","volume":"125","author":"van Altena","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.08.020_bb0050","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1477-7819-3-57","article-title":"Neoadjuvant chemotherapy versus primary surgery in advanced ovarian carcinoma","volume":"3","author":"Hegazy","year":"2005","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.ygyno.2013.08.020_bb0055","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/01.AOG.0000192407.04428.bb","article-title":"Aggressive surgical effort and improved survival in advanced-stage ovarian cancer","volume":"107","author":"Aletti","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2013.08.020_bb0060","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/j.1525-1438.2005.00135.x","article-title":"Port-site metastases after open laparoscopy: a study in 173 patients with advanced ovarian carcinoma","volume":"15","author":"Vergote","year":"2005","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2013.08.020_bb0065","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.ygyno.2004.11.031","article-title":"Role of laparoscopy to assess the chance of optimal cytoreductive surgery in advanced ovarian cancer: a pilot study","volume":"96","author":"Fagotti","year":"2005","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ygyno.2013.08.020_bb0070","first-page":"455","article-title":"Diagnostic open laparoscopy in the management of advanced ovarian cancer","volume":"100","author":"Angioli","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2013.08.020_bb0075","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ygyno.2008.04.042","article-title":"External validation of a laparoscopic-based score to evaluate resectability of advanced ovarian cancers: Clues for a simplified score","volume":"10","author":"Brun","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.08.020_bb0080","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1148\/radiology.215.3.r00jn25761","article-title":"Staging of advanced ovarian cancer: comparison of imaging modalities\u2013Report from the Radiological Diagnostic Oncology Group","volume":"215","author":"Tempany","year":"2000","journal-title":"Radiology"},{"key":"10.1016\/j.ygyno.2013.08.020_bb0085","first-page":"3223","article-title":"Radiological staging of ovarian cancer: imaging findings and contribution of CT and MRI","volume":"17","author":"Kubik-Huch","year":"2007","journal-title":"Radiology"},{"key":"10.1016\/j.ygyno.2013.08.020_bb0090","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s003300051000","article-title":"Value of (18F)-FDG positron emission tomography, computed tomography, and magnetic resonance imaging in diagnosing primary and recurrent ovarian carcinoma","volume":"10","author":"Kubik-Huch","year":"2000","journal-title":"Eur Radiol"},{"key":"10.1016\/j.ygyno.2013.08.020_bb0095","first-page":"1369","article-title":"A Combined PET\/CT Scanner for Clinical Oncology","volume":"41","author":"Beyer","year":"2000","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ygyno.2013.08.020_bb0100","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1148\/rg.312105713","article-title":"Role of FDG PET\/CT in staging of recurrent ovarian cancer","volume":"31","author":"Son","year":"2011","journal-title":"Radiographics"},{"key":"10.1016\/j.ygyno.2013.08.020_bb0105","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1007\/s00259-010-1416-2","article-title":"Clinical value of FDG PET\/CT in the diagnosis of suspected recurrent ovarian cancer: is there an impact of FDG PET\/CT on patient management?","volume":"37","author":"Bilici","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ygyno.2013.08.020_bb0110","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s00259-006-0260-x","article-title":"Role of [18F]FDG PET\/CT in the assessment of suspected recurrent ovarian cancer: correlation with clinical or histological findings","volume":"34","author":"Chung","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ygyno.2013.08.020_bb0215","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ygyno.2009.10.059","article-title":"Diagnosis and staging of primary ovarian cancer : correlation between PET\/CT, Doppler US, and CT or MRI","volume":"116","author":"Nam","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.08.020_bb0115","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/MNM.0b013e3281afa256","article-title":"Diagnostic accuracy of 18F-FDG PET\/CT in characterizing ovarian lesions and staging ovarian cancer: Correlation with transvaginal ultrasonography, computed tomography, and histology","volume":"28","author":"Castellucci","year":"2007","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.ygyno.2013.08.020_bb0120","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ijgo.2008.02.019","article-title":"Preoperative evaluation of pelvic masses with combined 18F-fluorodeoxyglucose positron emission tomography and computed tomography","volume":"102","author":"Yamamoto","year":"2008","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.ygyno.2013.08.020_bb0125","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ygyno.2006.11.022","article-title":"The diagnostic value of PET\/CT for primary ovarian cancer-A prospective study","volume":"105","author":"Risum","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.08.020_bb0130","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1007\/s00259-008-0890-2","article-title":"Diagnostic accuracy of integrated FDG-PET\/contrast-enhanced CT in staging ovarian cancer: comparison with enhanced CT","volume":"35","author":"Kitajima","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ygyno.2013.08.020_bb0135","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/MNM.0b013e328345b339","article-title":"FDG PET\/CT for diagnosis of primary ovarian cancer","volume":"32","author":"Kitajima","year":"2011","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.ygyno.2013.08.020_bb0140","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3109\/0284186X.2010.500296","article-title":"Standardized FDG uptake as a prognostic variable and as a predictor of incomplete cytoreduction in primary advanced ovarian cancer","volume":"50","author":"Risum","year":"2011","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ygyno.2013.08.020_bb0145","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2214\/ajr.182.1.1820227","article-title":"Incremental benefits of FDG positron emission tomography over CT alone for the preoperative staging of ovarian cancer","volume":"182","author":"Yoshida","year":"2004","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.ygyno.2013.08.020_bb0150","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ygyno.2012.04.023","article-title":"FDG PET\/CT in staging of advanced epithelial ovarian cancer: Frequency of supradiaphragmatic lymph node metastasis challenges the traditional pattern of disease spread","volume":"126","author":"Hynninen","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.08.020_bb0155","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ygyno.2009.12.008","article-title":"Does the use of diagnostic PET\/CT cause stage migration in patients with primary advanced ovarian cancer?","volume":"116","author":"Risum","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.08.020_bb0160","first-page":"341","article-title":"Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group","author":"Timmerman","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.ygyno.2013.08.020_bb0165","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ygyno.2012.09.013","article-title":"Neoadjuvant chemotherapy in advanced ovarian cancer: On what do we agree and disagree?","volume":"128","author":"Vergote","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.08.020_bb0170","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/bimj.201200026","article-title":"Discrimination ability of prediction models for ordinal outcomes: relationships between existing measures and a new measure","volume":"54","author":"Van Calster","year":"2012","journal-title":"Biom J"},{"key":"10.1016\/j.ygyno.2013.08.020_bb0175","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00259-004-1703-x","article-title":"Physiological 18F-FDG uptake in the ovaries and uterus of healthy female volunteers","volume":"32","author":"Nishizawa","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ygyno.2013.08.020_bb0180","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1102\/1470-7330.2006.0005","article-title":"Supra-clavicular lymph node metastatic spread in patients with ovarian cancer disclosed at 18F-FDG-PET\/CT: an unusual finding","volume":"6","author":"Fanti","year":"2006","journal-title":"Cancer Imaging"},{"key":"10.1016\/j.ygyno.2013.08.020_bb0185","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s00259-011-1984-9","article-title":"Prognostic significance of mediastinal 18F-FDG uptake in PET\/CT in advanced ovarian cancer","volume":"39","author":"Bats","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ygyno.2013.08.020_bb0190","first-page":"1","article-title":"FDG-PET\/CT in advanced ovarian cancer staging: Value and pitfalls in detecting lesions in different abdominal and pelvic quadrants compared with laparoscopy","author":"De Iaco","year":"2010","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.ygyno.2013.08.020_bb0195","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000071525","article-title":"Positron emission tomography with FDG in the detection of peritoneal and retroperitoneal metastases of ovarian cancer","volume":"55","author":"Drieskens","year":"2003","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.ygyno.2013.08.020_bb0200","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ygyno.2005.06.019","article-title":"Combined PET\/CT for detecting recurrent ovarian cancer limited to retroperitoneal lymph nodes","volume":"99","author":"Bristow","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.08.020_bb0205","first-page":"752","article-title":"Detection of unexpected additional primary malignancies with PET\/CT","volume":"46","author":"Ishimori","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ygyno.2013.08.020_bb0210","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00259-005-0056-4","article-title":"The presentation of malignant tumours and pre-malignant lesions incidentally found on PET-CT","volume":"33","author":"Even-Sapir","year":"2006","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825813011050?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825813011050?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,13]],"date-time":"2018-10-13T18:21:33Z","timestamp":1539454893000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825813011050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0090825813011050"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2013.08.020","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PET\/CT in the staging of patients with a pelvic mass suspicious for ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2013.08.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}